Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19
Clinical trial NCT05184218 · TERMINATED
Trial details
- NCT number
- NCT05184218
- Sponsor
- IGM Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-20
- Primary completion
- 2022-05-06
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.